The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancerRaffaella Soldi, Sunil Sharma, Jessica D. Lang et al.|PLoS ONE|2020Cited by 82
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancerRaffaella Soldi, Sunil Sharma, Jessica D. Lang et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 19
Abstract 3869: The reversible LSD1 inhibitor SP-2509 promotes anti-tumor immunity in small cell carcinoma of the ovary-hypercalcemic type (SCCOHT)Raffaella Soldi, Sunil Sharma, William P.D. Hendricks et al.|Cancer Research|2019Cited by 3